Moshe Elkabets

Senior Academic

Erratum for the research article

mTORC1 inhibition is required forsensitivity to PI3K p110a inhibitors in PIK3CA-mutant breast cancer (Science Translational Medicine DOI: 10.1126/scitranslmed.3005747)

M. Elkabets, S. Vora, D. Juric, N. Morse, M. Mino-Kenudson, T. Muranen, J. Tao, A. B. Campos, J. Rodon, Y. H. Ibrahim, V. Serra, V. Rodrik-Outmezguine, S. Hazra, S. Singh, P. Kim, C. Quadt, M. Liu, A. Huang, N. Rosen, J. A. Engelman, M. Scaltriti, J. Baselga

In the Research Article "mTORC1 Inhibition Is Required for Sensitivity to PI3K p110á Inhibitors in PIK3CA-Mutant Breast Cancer," the authors have provided additional competing interests upon request by the editors, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Publication language	English
Journal	Science Translational Medicine
Volume	10
Issue number	468
Publication status	Published - 14.11.2018
	eaav9425

ASJC Scopus subject areas

General Medicine